drugset / Trial / NCT00577018

Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation

NCT00577018

Phase 3 Completed 755 enrolled Movetis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety profile of 4 mg prucalopride in the treatment of chronic constipation.

Timeline

Start
1998-08
Primary completion
1999-09
Completion
1999-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 4 mg

Indications